FuraginAnti-bacterial, nitrofurantoin analog CAS# 1672-88-4 |
- Calyculin A
Catalog No.:BCC2457
CAS No.:101932-71-2
- Calcineurin Autoinhibitory Peptide
Catalog No.:BCC2456
CAS No.:148067-21-4
- DL-AP3
Catalog No.:BCC2459
CAS No.:20263-06-3
- Ceramide
Catalog No.:BCC2458
CAS No.:3102-57-6
- Fostriecin sodium salt
Catalog No.:BCC2460
CAS No.:87860-39-7
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 1672-88-4 | SDF | Download SDF |
| PubChem ID | 6870646 | Appearance | Powder |
| Formula | C10H8N4O5 | M.Wt | 264.19 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Synonyms | Furazidine; Furazidin | ||
| Solubility | DMSO : ≥ 33 mg/mL (124.91 mM) *"≥" means soluble, but saturation unknown. | ||
| Chemical Name | 1-[(E)-[(E)-3-(5-nitrofuran-2-yl)prop-2-enylidene]amino]imidazolidine-2,4-dione | ||
| SMILES | C1C(=O)NC(=O)N1N=CC=CC2=CC=C(O2)[N+](=O)[O-] | ||
| Standard InChIKey | DECBQELQORZLLP-UAIOPKHMSA-N | ||
| Standard InChI | InChI=1S/C10H8N4O5/c15-8-6-13(10(16)12-8)11-5-1-2-7-3-4-9(19-7)14(17)18/h1-5H,6H2,(H,12,15,16)/b2-1+,11-5+ | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Furagin, nitrofurantoin analog, is an anti-bacterial agent. Furagin is 2-substituted 5-nitrofuran, chemically and structurally similar to well-known antibacterial compound nitrofurantoin.
IC50 Value:
Target: Antibacterial
in vitro: The furagin concentrations in serum remain several hours above the MIC concentrations of many pathogenic bacteria. Despite the high concentrations in serum, the urine levels of furagin were generally lower than those of nitrofurantoin. The 24 hr recoveries in urine were 8--13% for furagin and about 36% for nitrofurantoin [1].
in vivo: A time-independent increase in SCE frequency was found in lymphocytes of children treated with furagin. Total CA frequency did not differ significantly between groups of children with various duration of furagin treatment [2]. Women were randomised into two groups receiving either ciprofloxacin 250mg twice a day for 3 days (n=13) or furagin 100mg three times a day for 7 days (n=14). Median lengths of follow-up were 4 days and 5 days in the ciprofloxacin and furagin groups, respectively [3]. References: | |||||
Furagin Dilution Calculator
Furagin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.7852 mL | 18.9258 mL | 37.8515 mL | 75.7031 mL | 94.6289 mL |
| 5 mM | 0.757 mL | 3.7852 mL | 7.5703 mL | 15.1406 mL | 18.9258 mL |
| 10 mM | 0.3785 mL | 1.8926 mL | 3.7852 mL | 7.5703 mL | 9.4629 mL |
| 50 mM | 0.0757 mL | 0.3785 mL | 0.757 mL | 1.5141 mL | 1.8926 mL |
| 100 mM | 0.0379 mL | 0.1893 mL | 0.3785 mL | 0.757 mL | 0.9463 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Furagin is an anti-bacterial, nitrofurantoin analog with the same efficacy in treating acute cystitis as Ciprofloxacin; however, the duration of therapy is longer.
- R-96544 hydrochloride
Catalog No.:BCC7164
CAS No.:167144-80-1
- Autocamtide-2-related inhibitory peptide
Catalog No.:BCC7153
CAS No.:167114-91-2
- 10-Oxo Docetaxel
Catalog No.:BCC5409
CAS No.:167074-97-7
- Pitavastatin ethyl ester
Catalog No.:BCC9122
CAS No.:167073-19-0
- Fmoc-D-Cys(Trt)-OH
Catalog No.:BCC3481
CAS No.:167015-11-4
- BMS 453
Catalog No.:BCC7679
CAS No.:166977-43-1
- N-Acetoacetylmorpholine
Catalog No.:BCC9078
CAS No.:16695-54-8
- Tetramethylkaempferol
Catalog No.:BCN8082
CAS No.:16692-52-7
- 3-Amino-5-mercapto-1,2,4-triazole
Catalog No.:BCC8615
CAS No.:16691-43-3
- A-1210477
Catalog No.:BCC6508
CAS No.:1668553-26-1
- Chebulanin
Catalog No.:BCN3261
CAS No.:166833-80-3
- H-D-Orn-OH. HCl
Catalog No.:BCC3004
CAS No.:16682-12-5
- Clevidipine Butyrate
Catalog No.:BCC4401
CAS No.:167221-71-8
- Cyanidin 3-Sophoroside-5-Glucoside
Catalog No.:BCC8158
CAS No.:16727-02-9
- Malvidin 3,5-Diglucoside
Catalog No.:BCC8206
CAS No.:16727-30-3
- 9-Hydroxyeriobofuran
Catalog No.:BCN7444
CAS No.:167278-41-3
- Zosuquidar
Catalog No.:BCC2074
CAS No.:167354-41-8
- Fmoc-Lys(Mtt)-OH
Catalog No.:BCC3523
CAS No.:167393-62-6
- H-Cys(Bzl)-OMe.HCl
Catalog No.:BCC2907
CAS No.:16741-80-3
- Sophoracarpan A
Catalog No.:BCN6980
CAS No.:1674359-82-0
- Sophoracarpan B
Catalog No.:BCN6979
CAS No.:1674359-84-2
- LY335979 (Zosuquidar 3HCL)
Catalog No.:BCC3878
CAS No.:167465-36-3
- BADGE
Catalog No.:BCC7022
CAS No.:1675-54-3
- PD-1/PD-L1 inhibitor 2
Catalog No.:BCC6520
CAS No.:1675203-84-5
Ciprofloxacin and furagin in acute cystitis: comparison of early immune and microbiological results.[Pubmed:18060746]
Int J Antimicrob Agents. 2008 Feb;31(2):130-4.
Furagin (a nitrofurantoin analogue) has the same efficacy in treating acute cystitis as ciprofloxacin, however the duration of therapy is longer. We established a hypothesis that therapy with ciprofloxacin results in faster resolution of mucosal inflammation in comparison with Furagin. Rates of urinary secretion of immunoglobulins class A, M and G and interleukin-8 (IL-8) were evaluated before and after initiation of therapy in adult women presenting with acute cystitis confirmed by urine culture. Women were randomised into two groups receiving either ciprofloxacin 250mg twice a day for 3 days (n=13) or Furagin 100mg three times a day for 7 days (n=14). Median lengths of follow-up were 4 days and 5 days in the ciprofloxacin and Furagin groups, respectively. Treatment with ciprofloxacin resulted in faster eradication of pathogens. No bacteria or nitrates were detected in the ciprofloxacin group, whilst leukocyte esterase was positive in only one case. In the Furagin group there were four positive cultures, seven cases with positive nitrates and five cases with positive esterase. Secretion rates of all four substances dropped significantly, but the changes over time were similar in both groups.
[Pulmonary reaction after furazidin (Furagin). Case report].[Pubmed:9411425]
Pol Arch Med Wewn. 1997 May;97(5):465-72.
For the first time in Poland we present the case of pulmonary reaction to furazidin which is by chemical structure closely related to nitrofurantoin. 63 years old woman presented generalized symptoms of acute hypersensitivity reaction induced by furazidin as well as features of chronic pulmonary fibrosis. After few months of treatment with this drug patients complained of weight loss, dyspnea on effort, non-productive cough, chills and fever. Radiological and functional evaluation of respiratory system confirmed features of lung fibrosis. Drug provocation test was positive. In vitro furazidin in low concentrations stimulated proliferation of patient's lymphocytes. After cessation of treatment we have observed rapid improvement of clinical, radiological, biochemical and functional parameters.
[Photosensitizing properties and antioxidant activity of furagin--an antimicrobial drug that is a derivative of nitrofuran].[Pubmed:9172693]
Biofizika. 1997 Mar-Apr;42(2):472-9.
Photosensitizing effect of antimicrobial drug nitrofuran derivative--Furagin N-(5-nitro-2-furil)-allylidencamino-hydantoin) under irradiation with light longer than 280 nm was found. The method of investigation is based on photochemiluminescence of Gly-Trp peptide in aqueous solution. Maximum photosensitizing efficiency was observed at the Furagin concentration 0.08 mM when chemiluminescence yield was 33 times greater than photochemiluminescence of Gly-Trp peptide in absence of drug. It was shown that photochemiluminescence sensitized by Furagin occurred via free radical way. Life time of the triplet state of Furagin determined by flash photolysis was 40 microseconds. A comparison of experimental data with kinetic calculation allowed us to estimate the rate constant of triplet quenching by oxygen ((2.2 +/- 0.3)10(8) M-1.s-1) and the total rate constants of physical quenching and chemical reaction with Gly-Trp peptide ((2.0 +/- 0.4)10(8) M-1.s-1). It was also found in experiments with photochemiluminescence of Gly-Trp peptide sensitized by riboflavin (irradiation with monochromatic light 436 nm) that Furagin possesses antioxidant properties twice reducing the intensity of chemiluminescence at the drug concentration 0.029 mM.
